Problem statement: Answer the MCQ question.
Query: Which drug exhibits a 3.881% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) O=C(c1ccccc1)c1c[nH]c(C(=O)NCCCn2ccnc2)c1
b.) CCN(C(=O)CSc1nnc(-c2ccc3c(c2)OCO3)o1)C1CCS(=O)(=O)C1
Answer: b. CCN(C(=O)CSc1nnc(-c2ccc3c(c2)OCO3)o1)C1CCS(=O)(=O)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(C(=O)CSc1nnc(-c2ccc3c(c2)OCO3)o1)C1CCS(=O)(=O)C1
CCN(C(=O)CSc1nnc(-c2ccc3c(c2)OCO3)o1)C1CCS(=O)(=O)C1
2-[[5-(1,3-benzodioxol-5-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(1,1-dioxothiolan-3-yl)-N-ethylacetamide